Impact of the interval between neoadjuvant immunochemotherapy and surgery on surgical–pathological outcomes in non-small cell lung cancer

INTRODUCTION: The interval between neoadjuvant immunochemotherapy and surgery in patients with non-small cell lung cancer (NSCLC) has not been well characterized. This study investigated the association between the time-to-surgery (TTS) interval and surgical–pathological outcomes. METHOD: Clinical d...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jiawei, Deng, Hongsheng, He, Jiaxi, Wang, Zhufeng, Li, Shuben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491272/
https://www.ncbi.nlm.nih.gov/pubmed/36158657
http://dx.doi.org/10.3389/fonc.2022.909726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491272/
https://www.ncbi.nlm.nih.gov/pubmed/36158657
http://dx.doi.org/10.3389/fonc.2022.909726

Ejemplares similares